Article

Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes…

Disease Markers · 2017 · Lianlian Pan, author Yali Ye, author Mingyi Wo, author Danni Bao, author Fengjiao Zhu, author Maoliang Cheng, author Xiuwen Ni, author Xianming Fei, author Michele Malaguarnera, Academic Editor

Key facts

Title Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy
First author Lianlian Pan, author Yali Ye, author Mingyi Wo, author Danni Bao, author Fengjiao Zhu, author Maoliang Cheng, author Xiuwen Ni, author Xianming Fei, author Michele Malaguarnera, Academic Editor
Journal Disease Markers
Published Aug 22, 2017
DOI 10.1155/2018/5214376
Devices mentioned K063351, K081895, K083906, K122126, K151259, K161312, K161317, K162420, K162688, K172333, K181082, K861700 and 2 more
Product codes mentioned CHH, JIS, JPA, JPK, LBS, LCP, NDY, JIT, JIX, JJY, JQB

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature